Cargando…

Rapamycin inhibits oral cancer cell growth by promoting oxidative stress and suppressing ERK1/2, NF-κB and beta-catenin pathways

Treatment of oral cancer is based exclusively on surgery combined with or without chemotherapy. However, it has several side effects. Targeting a new, more effective therapy has become an urgent matter. The purpose of this study was to evaluate the anti-tumor activity of rapamycin in oral cancer and...

Descripción completa

Detalles Bibliográficos
Autores principales: Semlali, Abdelhabib, Papadakos, Sofia, Contant, Camille, Zouaoui, Ikram, Rouabhia, Mahmoud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9520465/
https://www.ncbi.nlm.nih.gov/pubmed/36185289
http://dx.doi.org/10.3389/fonc.2022.873447